Treatment of chronic total occlusions in native coronary arteries by drug-coated balloons without stenting - A feasibility and safety study

Köln PJ 1 , Scheller B 2 , Liew HB 3 , Rissanen TT 4 , Ahmad WA 5 , Weser R 6 Show all authors , Hauschild T 7 , Nuruddin AA 8 , Clever YP 2 , Ho HH 9 , Kleber FX 10

Affiliations 

  • 1 Charité - Universitätsmedizin Berlin, Berlin, Germany
  • 2 Universitätsklinikum des Saarlandes, Homburg, Germany
  • 3 Sabah Heart Centre, Kota Kinabalu, Malaysia
  • 4 North Karelia Central Hospital, Joensuu, Finland
  • 5 University of Malaya Medical Center, Kuala Lumpur, Malaysia
  • 6 Evangelisches Krankenhaus Paul Gerhardt Stift, Lutherstadt Wittenberg, Germany
  • 7 Klinikum Ernst von Bergmann, Potsdam, Germany
  • 8 National Heart Institute, Kuala Lumpur, Malaysia
  • 9 Tan Tock Seng Hospital, Tan Tock Seng, Singapore, Singapore
  • 10 Cardio Centrum Berlin, Academic Teaching Institution, Charité - Universitätsmedizin Berlin, Berlin, Germany. Electronic address: post@fxkleber.de
Int J Cardiol, 2016 Dec 15;225:262-267.
PMID: 27741486 DOI: 10.1016/j.ijcard.2016.09.105

Abstract

Chronic total occlusions remain one of the biggest challenges for interventional cardiologists and the high risk of restenosis and stent thrombosis is still a major problem. Drug-coated balloons showed favorable results for the treatment of in-stent restenosis and other lesion types. The aim of this study was to evaluate the feasibility and outcome of a drug-coated balloon only approach for chronic total occlusion.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications